Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate

Acta Pharmacologica Sinica

Volumn 31, Issue 1, 2010, Pages 35-42

  Zhang, Ning ^a   Huan, Yi ^a   Huang, Hui ^a   Song, Guang Ming ^a   Sun, Su Juan ^a   Shen, Zhu Fang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Atorvastatin; HMG CoA reductase inhibitor; Insulin resistance; Monosodium glutamate; Obesity

Indexed keywords

ATORVASTATIN; CHOLESTEROL; FATTY ACID; GLUCOSE; GLUTAMATE SODIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY HEIGHT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID METABOLISM; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WESTERN BLOTTING;

ADIPOSE TISSUE; ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FEMALE; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MICE; MICE, INBRED ICR; OBESITY; PYRROLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SODIUM GLUTAMATE;

EID: 74549124257     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.176     Document Type: Article

References (33)

1. Bosello O, Zamboni M. Visceral obesity and metabolic syndrome. Obes Rev 2000; 1: 47-56.
2. Christian H, Sophie S, Wolfgang R, Burkhard H, Heiko S, Horst W, et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 2007; 92: 4569-74.
3. Koistinen HA, Forsgren M, Wallberg HH, Zierath JR. Insulin action on expression of novel adipose genes in healthy and type 2 diabetic subjects. Obes Res 2004; 12: 25-31.
4. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106: 473-81.
5. Paz K, Hemi R, LeRaith D, Karasik A, Elhanany E, Kanety H, et al. A molecular basis for insulin resistance: elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxta membrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 1997; 272: 29911-8.
6. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity induced insulin resistance. Science 1996; 271: 665-8.
7. Tanti JF, Grémeaux T, van Obberghen E, Le Marchand-Brustel Y. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem 1994; 269: 6051-7.
8. Hong R, Nir H, Todd RG, Luk VP, Harvey FL. Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-α is obligatory. Diabetes 2002; 51: 1319-36.
9. Prigent M, Barlat I, Langen H, Dargemont C. IκBα and IκBα/NF-κB complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2. J Biol Chem 2000; 275: 36441-9.
10. Esther L, Mat D. HMG-CoA reductase inhibitors: lipid-lowering and beyond. Drug Discov Today Ther Strateg 2004; 1: 189-94.
11. Wolfgang D, Jozef D, Matthias F, Hannes FA, Severin PS, Mikko A, et al. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003; 23: 58-63.
12. Macho L, Ficková M, Jezová, Zórad S. Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats. Physiol Res 2000; 49: S79-85.
13. Tokushi K, Fumiaki I, Satoshi M, Koichi H. Gene expression of resistin in adipose tissue and mammary gland of lactating and non-lactating cows. J Endocrinol 2003; 178: R1-R5.
14. Shana S, Zhao BP, Yang JZ. Enhanced muscle by myostatin propeptide increases adipose tissue adiponectin, PPAR-α and PPAR- ? expressions. Biochem Biophys Res Commun 2008; 369: 767-73.
15. Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D, et al. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 2007; 583: 9-24.
16. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 193-205.
17. Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res 2008; 102: 401-414
18. Engstrom G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L, et al. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 2003; 52: 442-447 (Pubitemid 36173201)
19. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001; 25: 1407-1415
20. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978
21. Paolisso G, Barbagallo M, Petrella G, Ragno E, Barbieri M, Giordano M, et al. Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients. Atherosclerosis 2000; 150: 121-7.
22. Farrer M, Winocour PH, Evans K, Neil HA, Laker MF, Kesteven P, et al. Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures. Diabetes Res Clin Pract 1994; 23: 111-9.
23. Ohrvall M, Lithell H, Johansson J, Vessby B. A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia. Metabolism 1995; 44: 212-7.
24. Hirata AE, Andrade IS, Vaskevicius P, Dolnikoff MS. Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz J Med Biol Res 1997; 30: 671-4.
25. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-332
26. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978
27. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280: E745-51.
28. Peter S, David JL. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci 2003; 100: 7265-70.
29. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 2008; 14: 222-31.
30. Shoelson SE, Lee J, Yuan M. Inflammation and the IKKβ/IκB/NF- κB axis in obesity- and diet-induced insulin resistance. Int J Obes 2003; 27: 49-52.
31. Victor C, Melvin K, Charles R, Cheryl H, Jeffrey T. The genotoxicity profile of atorvastatin, a new drug in the treatment of hypercholesterolemia. Mutat Res 1995; 343: 95-107.
32. Clarke AT, Mills PR. Atorvastatin associated liver disease. Dig Liver Dis 2006; 38: 772-7.
33. Harris WS. n-3 Fatty acids and serum lipoproteins: animal studies. Am J Clin Nutr 1997; 65: 1611S-1616S.